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Background: Recruitment of sufficient participants in an efficient manner is still widely acknowledged to be a
major challenge to the mounting and completion of randomised controlled trials (RCTs). Few recruitment
interventions have involved staff undertaking recruitment. This study aimed i) to understand the recruitment
process from the perspective of recruiters actively recruiting RCT participants in six pragmatic RCTs, and ii) to
identify opportunities for interventions to improve recruitment.
Methods: Interviews were undertaken with 72 individuals (32 doctors or RCT Chief investigators (CIs); 40 nurses/
other health professionals) who were actively recruiting participants in six RCTs to explore their experiences of
recruitment. The RCTs varied in scale, duration, and clinical contexts. Interviews were fully transcribed and analysed
using qualitative content and thematic analytic methods derived from grounded theory. For this analysis, data were
systematically extracted from each RCT and synthesised across all six RCTs to produce a detailed and nuanced
understanding of the recruitment process from the perspectives of the recruiters.
Results: Recruiters readily identified organisational difficulties, fewer than expected eligible patients, and patients’
treatment preferences as the key barriers to recruitment. As they described their experiences of recruitment, several
previously hidden issues related to their roles as researchers and clinicians emerged, imbued with discomfort and
emotion. The synthesis across the RCTs showed that doctors were uncomfortable about aspects of patient eligibility
and the effectiveness of interventions, whereas nurses were anxious about approaching potential RCT participants
and conflicts between the research and their clinical responsibilities. Recruiters seemed unaware that their views
contributed to recruitment difficulties. Their views were not known to RCT CIs. Training and support needs were
identified for both groups of staff.
Conclusions: The synthesis showed that recruitment to these RCTs was a complex and fragile process. Clear
obstacles were identified but hidden challenges related to recruiters’ roles undermined recruitment, unbeknown to
RCT CIs. Qualitative research can elicit and identify the hidden challenges. Training and support are then needed for
recruiters to become more comfortable with the design and principles of RCTs, so that they can engage more
openly with potentially eligible participants and create a more resilient recruitment process.
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Recruitment of sufficient eligible participants is widely
acknowledged to be a major challenge to randomised
controlled trials (RCTs), leading to underpowered studies,
additional resources spent on costly extensions and, in
some cases, the inability to tackle key healthcare questions
[1,2]. Several systematic reviews have identified particular
issues that RCTs need to address in order to recruit
successfully, including that the RCT must tackle an
important and timely question, with a clear protocol and
straightforward and low impact data collection [2-4],
employ dedicated research staff [2,3], ensure prior planning
and piloting of recruitment [2,3], ensure good com-
munication and training for staff about trial processes and
interventions [2,5], and use proven effective recruitment
strategies [6]. These sensible and practical suggestions are
mostly drawn from the experience of trialists and from
individual RCTs; only a very small number of robust
interventions have been shown to improve recruit-
ment, including telephone reminders or financial induce-
ments [7], newsletters and mail-shots to encourage
non-responders [2], and opt-out rather than opt-in
schemes for participants [6].
Recruitment is an interactional activity and typically
occurs after at least two meetings between a potential
participant and clinical and/or researcher staff, initially
to establish whether the participant is eligible for the
RCT according to the formal criteria in the protocol,
and then, if they are, the provision of information about
the details of the RCT and discussion about a decision
to participate, concluded by the signing of a consent
form. The length and complexity of this process is in
sharp contrast with the tendency of the interventions
above to focus on particular practical matters. It is also
remarkable that systematic reviews have consistently
indicated the importance of recruiters in RCT recruitment,
but there is still little understanding of the perspective
of recruiters and very few interventions that have been
targeted at recruitment staff [6]. Few studies have even
considered how the process of recruitment occurs, or the
influence that recruiters might have on it. A study
using qualitative research methods integrated in one RCT
developed a complex intervention based on an under-
standing of the recruitment process from the perspective
of recruiters [8]. Attempts were then made to apply the
intervention to other RCTs, but a number of difficulties
were experienced [9].
This paper seeks to build on that qualitative research
to produce a detailed understanding of the recruitment
process from the perspective of active recruiters through
an investigation of recruitment in six independent,
pragmatic, publicly-funded RCTs with complex interven-
tions ranging across a number of clinical centres and
contexts. The RCTs were either experiencing severerecruitment problems, or were pilot/feasibility studies
expecting difficulties, and each had included or added an
embedded qualitative study to understand the recruitment
process, particularly from the perspective of recruiters,
based on an intervention developed in the first RCT
studied [8]. Data were collected in each of the six RCTs
from recruitment staff (doctors, nurses, and researchers)
in interviews while they were actively trying to recruit
RCT participants and in this article these data have been
synthesised across the RCTs to produce a detailed and
nuanced understanding of recruitment by recruiters.
Many barriers to recruitment were identified. Often, as
suggested from previous research, these seemed to be
related to organisational challenges or the discovery that
large numbers of eligible patients had strong preferences
for particular interventions. As recruiters reflected on
their experiences of recruitment in the interviews, a number
of other underlying and somewhat hidden issues emerged,
associated with their views about research and their
roles in research and clinical care. The findings exposed
issues underlying the fragility of RCT recruitment, and, in
turn, enabled the identification of opportunities to develop
more resilient and effective recruitment processes that
should improve efficiency as well as experiences for
recruiters and patients.
Methods
The research was undertaken in six publicly-funded
RCTs in a range of clinical contexts, with different types
of RCT intervention, with a range of primary recruiters,
and at different stages of the implementation of the RCT
(Table 1) [9]. Qualitative research methods were used to
ensure detailed exploration of the perspectives of re-
cruitment by active recruitment staff and some RCT
methodologists. In-depth interviews were conducted in
each of the RCTs, using a checklist of topics to ensure
that similar issues were covered whilst enabling other
issues of importance to emerge. Interviews were conducted
by ZT, SP, IdS, MT, or GDW, mostly face-to-face and
one-to-one. Opportunities were taken on six occasions to
discuss emerging issues with groups when they met as
part of the conduct of the RCT. In four RCTs, there
was sufficient time for follow-up interviews to be carried
out amongst a subsample, enabling some recruiters to
reflect on the issues raised by the studies and the feedback
they had received. Consent was obtained for interviews
and discussions to be audio-recorded. Ethical approval
was obtained from the bodies listed below (additional
information).
Interviews and discussions were transcribed in full and
analysed using qualitative content and thematic analysis
methods, based on the techniques of constant comparison
from grounded theory [10,11]. The researchers, ZT, IdS,
MT, and SP, coded the interview transcript data for each
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software. A basic coding framework was developed by the
team and applied to the data from each RCT separately to
identify themes relating to the process of recruitment [12].
A detailed descriptive account of the thematic findings
was then produced, providing a summary and holistic
(ethnographic) account of the recruitment process in each
RCT. This was then used to provide anonymised feedback
to the RCT chief investigator (CI) and develop information
provision and training for recruiters [9]. For this
manuscript, JLD first considered the summary accounts
from each RCT to identify recruitment issues that were
similar or different between the RCTs. This provided a
framework, but for a full synthesis, the original data from
the interview transcripts in all six RCTs were extracted
and systematically coded by JLD to synthesise the themes
across the RCTs, focusing on recruiters’ perceptions and
experiences of the recruitment process, the barriers they
identified, and the exploration of other issues that were
inhibiting or facilitating recruitment. The findings of this
synthesis are presented here.
Results
Characteristics of RCTs and participants
The six RCTs were funded by several major UK public
funding bodies and their clinical contexts included cancer
surgery, oncology, paediatrics, and psychiatry/mental
health (Table 1). They included a variety of interventionsincluding drugs, surgery, radiotherapy, and social support.
Two of the RCTs (T1 and T7) were feasibility studies in
which the CI anticipated recruitment difficulties; T2, T3,
and T5 were full-scale RCTs where recruitment had not
initially been expected to be problematic; and T6 included
a feasibility phase where recruitment difficulties were
anticipated and a main, successfully recruiting phase.
Interviews were undertaken with 72 individuals who were
actively recruiting participants (32 were doctors or RCT
CIs, 40 were nurses or other health professionals). The
doctors were all employed by the NHS and carried out
eligibility assessments and recruitment in all but T5
(where this was done by clinical care coordinators) as part
of their combined clinical and research roles. The nurses
in T3 and T6 were employed by the RCT as research
nurses, and T5 employed a researcher specifically to
undertake recruitment. In contrast, T1, T2, and T7 relied
primarily on research nurses employed by the National
Cancer Research Network (NCRN), who were trained
centrally to recruit patients to all available RCTs.
In each RCT, the CI and between one and three Trial
Management Group (TMG) members were interviewed
to provide an overview of the RCT, and a sample of
active recruiters was also approached, including the
principal investigators of clinical centres and other staff.
There were 15 follow-up interviews in the RCTs where
funding was available for this, seven with individuals in
T6 and eight in groups in T1, T2, and T5. Most
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groups (Table 1). The qualitative studies were added to
the RCTs over an extended period of time, and so initial
interviews were conducted in 2001/2002 in T6; in 2005
for T1, T2, and T3; 2006 for T5; and 2009 for T7. In T1,
T2, T6, and T7, medically qualified and nursing staff
were involved in recruitment; in T3 and T5, the primary
recruiters were nurses or other staff.
In the presentation of the results below, RCTs and par-
ticipants have been anonymized to protect confidentiality.
Each staff member has been labelled according to the
RCT (e.g., T7); whether they were a doctor, CI, or member
of the TMG (e.g., –D9), a nurse or other health professional
(−N7); and whether the interview was individual (no
label), group (−G) or follow-up (−F).
Understanding recruitment: recruiter perspectives
All recruiters readily described the barriers that they
were convinced hindered recruitment. The clearest and
most common barriers were organisational difficulties,
fewer eligible patients than anticipated, and strong pref-
erences expressed by patients for particular treatments
or against being randomised:
T2–D1: “The actual difficulty was in the logistics and
it’s usually because the nurse can’t attend the clinic or
the nurse can’t attend the meeting or the
multidisciplinary team doesn’t actually go through the
list of patients that are eligible at that time.”
T1–D2: “So, so there’s a local nuance there that we do
get a significant number of patients who will plump for
[intervention 1] if they live in [district a]. They don’t
want to travel. They live next to the [intervention 1]
centre which is I guess, what, ten miles difference or
something like that, eight, ten miles? And conversely
patients will plump for [intervention 2] for the fact that
it’s going to happen in the hospital down the road.”
T1–N2–FG: “All the patients that have said ‘no’, have
said ‘no’ for personal reasons, not because of anything
that we could change. One of them didn’t want a
computer to decide what was happening about his
treatment, he had to have control over his own destiny,
and he just didn’t like the idea of being randomised.”
These barriers were consistently reported and recruiters
often seemed overwhelmed by the difficulties, leading to
low morale and very poor recruitment levels:
T7–D5: “I’m a genuine believer in the principle that
[intervention 1] might be as good as [intervention 2]
and therefore I’m a strong supporter of the basis of this
trial … But it’s been a nightmare, frankly … I love thistrial. I think it’s beautifully designed, I think it is
extremely clever, which fits [name of CI] who is
extremely clever … But, I honestly have never had as
many problems with recruiting to a trial in all my
born days.”
As would be expected, the leaders of the RCTs tried
hard to find solutions to these difficulties, by changing
organisational arrangements of clinics, or making sure
that all potentially eligible patients could be included:
T1–N2–FG: “The patients get the diagnosis and they
see the surgeon and the oncologist on the same day.
They mention [RCT] to the patients and then if they
want to go in it, they refer the patient to me then they
come in to me sometime in the next week or so …
They’ve had both treatments explained to them a
couple of days ago by the time they get to me, so it’s
quite good.”
T7–D4: “[We are going to] make certain that all
potentially eligible patients have a discussion about
the trial and know that it’s available for them … have
a research nurse attending the MDT [multi-
disciplinary team meeting, where treatments are
decided]. In terms of the organisational things, it’s
challenging, but it’s not impossible.”
Some organisational changes slightly improved recruit-
ment in some RCTs, but it remained problematic. Re-
cruiters had been encouraged, in the interviews, to
recount their actual experiences of recruitment in detail.
As they did so, it became apparent that there were issues
associated with their role as a recruiter that they found
difficult, particularly in relation to their other roles as
practising doctors or nurses. As they described their roles
and the challenges and conflicts within them, they began
to express emotion and discomfort, sometimes defensive-
ness, and a number of previously hidden challenges to
recruitment emerged; these are detailed below.‘Hidden’ challenges: complex roles
Recruiters had several roles, some perceived to be com-
plementary, and others conflicting. While there were
some similarities between some doctors and nurses,
there was much more coherence within each of the pro-
fessional groups and considerable differences between
them, and so their views are presented separately below.
While the recruiters eagerly described their roles and
their challenges and expressed their views freely to the
interviewer, very few linked their views or feelings with
an impact on RCT recruitment or had raised these
issues with the RCT leads.
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Doctors were involved in recruitment in all these RCTs,
most in assessments of eligibility and sometimes under-
taking the process of informed consent on their own or
with the assistance of nurses or other researchers. When
asked directly, these doctors described themselves as sci-
entists or practising clinicians, or some combination of
the two. Some were clear that these roles were comple-
mentary, and that it was really important to them to be
able to combine the often urgent need to collect robust
evidence through RCTs with a clinical role.
T3–D1: “I see my role as a researcher and as a
clinician as engaging my patients and the community
out there in a long-term relationship, not just for
today, not just for this child, not just for this illness,
but a long-term relationship for us together, to improve
clinical practice and reduce uncertainty. And that’s
about saying to people ‘okay that’s fine this time you
don’t want to do it perhaps another time you will,
perhaps another time the condition will be the right
one for you or the timing will be better’.”
T6–D11: “I’m convinced fully about what I’m doing …
Unless we take this attitude of impartiality we will not
find out and we will continue to over-treat patients or
to under-treat patients.”
When asked directly, the doctors were positive about
their involvement in the RCT and their commitment to
it, but then went on to describe a number of underlying
conflicts with clinical practice that they experienced to
varying degrees. These related particularly to the balance
between carrying out research and ensuring that they
safeguarded the best interests of the individual patient,
and their willingness or ability to suspend their clinical
judgments and recruit an individual patient to the RCT.
In talking about the RCT, it was easy for them to agree
that there was a lack of evidence about the most suitable
treatment in general, but many admitted that when faced
with a particular patient, or those with specific clinical
characteristics, they became more uncomfortable:
T7–D2: “There’s always a slight conflict between the
patient sitting in front of you and their wishes but also
taking part in the trial and wanting to support the
trial, wanting to increase recruitment. Yes and it’s an
element of frustration when someone says, ‘no’. So there
can be a conflict between your management
responsibilities for an individual compared to your
wish to make something else a success.”
T6–D2–F: “Sometimes you get the feeling that we are
counselling them to the extent that you are doing adisservice to them. Are you helping or hindering their
management when you yourself know there are so
many uncertainties and at the moment, or as far as
you know, there are controversies, but all treatments
can be similar with minute variations … So, it’s
inevitable at that times you feel uncomfortable.”
Some went on to describe particular patients or groups
of patients who were technically eligible for the RCT,
but who they felt were not really suitable and were either
uncomfortable about recruiting, or definitely would not
recruit:
T6–D12: “I wouldn’t be involved with the trial because
it wouldn’t be ethical if I had a strong view that this
wasn’t right … But, there are a subset of younger men
with more aggressive tumours where I find that really
quite difficult.”
T7–D6: “My bias is that in a younger person,
[intervention 1] probably is a better treatment …
Rather than putting them into trial, I think what I’d
like to do is give them [intervention 1] up-front.”
While doctors continued to identify recruitment barriers
as being organisational difficulties, the lack of patients
fitting the RCT eligibility criteria, and patients expressing
strong treatment preferences or rejecting randomisa-
tion, a careful analysis of the interview data indicated
that these obstacles were not quite as straight-forward
as they seemed. In the interviews, doctors readily
expressed considerable discomfort and difficulty in
relation to their roles as clinicians and recruiters, par-
ticularly around the eligibility of particular patients or
groups, and their own treatment preferences, clinical
instincts, and ability to feel uncertain about the most
appropriate treatment. Many of these barriers seemed
to originate from the doctors’ views or at least to be
reinforced by their views. Their lack of equipoise for
groups or individual patients contributed to the lack
of eligible participants as they did not recruit those
outside their comfort zone. If patients expressed the
same preference for a treatment as the clinician, it
was easy to allow them to have that treatment rather
than offer recruitment to the RCT:
T6–D9: “If you believe [intervention 1] is the best
for them, you should say so … There’s somebody
I saw recently … I actually took him off the trial.
I said, ‘Well you’d be better off [with intervention 1
rather than intervention 2]’. So it’s a small number
of people, but I hope I would offer them what
I thought was the best treatment and take them out of
the trial.”
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with preconceived ideas and in a lot of cases with their
mind made up, and they’re checking that prejudice out,
if you like, with the doctor when they come in.”
T2–D2: “I think there is a problem with equipoise …
There are patients whom [specialists] regard as really
high risk and they would be uncomfortable about
putting them in, so they don’t actually.”
Doctors were thus able to express commitment to the
RCT because of the need to gather evidence but also
considerable discomfort about particular aspects of re-
cruitment, only rarely linking their views to recruitment
problems.
2. Nurses’ roles
Nurses were employed as the primary recruiters in T3
and in the main recruitment phase of T6, and were
closely involved in recruitment in the other RCTs as
network nurses (T1, T2, T7) or care co-ordinators (T5).
They discussed their roles in great detail, identifying
three major aspects: caring clinical nurse, patient advocate,
and recruiter/scientist. All the nurses perceived potential
conflicts between these roles, particularly on the boundary
between recruiter and caring nurse. Only a very small
number thought their caring and recruiting roles could be
complementary, but even they struggled with how to
accommodate advocacy:
T7–N2: “I hope that one complements the other
really, rather than be conflicting. If it’s a study that
I’m involved in then I think my background as a
nurse would be – I would be there in a supportive
sort of role, and also to be able to put something
across to a patient where I felt that they didn’t feel
intimidated, that they didn’t feel that they had to go
into something, that it was, you know, really their
choice to do that. I mean if you’re thinking about
being an advocate, I don’t think that as a research
nurse I can be.”
The most common and powerful view that emerged was
how concerned nurses were about the conflicts they per-
ceived between caring for patients and recruiting them to
RCTs. The boundary between research and clinical activity
was a particular source of anxiety, and for those relatively
new to research, adapting to a combined role was seen to
be very challenging because of the differences they per-
ceived in their status, employment, and the purpose of
their activity:
T3–N1: “I had to learn to adjust to quite a different
role where actually I very much had to be invited to gointo their family rather than being the person who’s
going to go there and help them because although
there is an element of that to my job, it’s not my
main job. My main job is the research and to recruit.
We’re not in uniform, because our first role is not as
one of a nurse, it’s a researcher and I’m not employed
as a nurse, I’m employed as a research associate by
[University] … How will I know when I should be a
nurse and when I should be a researcher? It’s really
hard and there’ve been a couple of times when I’ve got
a bit confused about that and thankfully it hasn’t led
to anything drastic.”
T2–N3: “I haven’t had a real conflict yet, but I can
imagine that sometimes it would be … You know, how
many times do you pursue them, how many times do
you say? And there is the bottom line that they want
us to recruit people to these trials, don’t they?
Obviously, in order for them to be a success, so you do
feel, yes I do sometimes feel like a salesman.”
When asked directly, most of the nurses stated that they
enjoyed their roles as recruiters and their involvement in
the RCTs, but as they discussed these issues in more detail
in the interviews, it was clear that many of them wanted
to define their position as caring clinical nurses, and they
defended that role tenaciously. The primacy of their clin-
ical/caring role was often asserted strongly, sometimes
defensively, and many ensured their clinical role took pre-
cedence over the RCT:
T6–N3–G: “I just tell them that they’re in control
whatever they decide to do. If they decide to
randomise, fine; if they reject the randomised
treatment, fine; if they decide that they want the
randomised treatment – whatever they choose to
do as long as it’s an informed choice and I am
satisfied it’s an informed choice, it’s entirely up to
them. They’re in control of the whole process … We
are nurses, we are here for them … We will support
them through it because they are our priority. They
come first, last and always. And that doesn’t always
fit well with sort of, academics, but that is what we’re
here for.”
T2–N2: “I always have the patient’s best interests
at heart at the expense of the research. I’m not
here to recruit patients onto trials and I always
say to them, ‘I don’t mind what you do, the decision
is yours, and if you’re not happy to do the trial,
don’t do it.’ I would never recruit anyone that
I didn’t feel was happy. I’d never talk them into
doing it because that’s not – I am a nurse first and
foremost.”
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the (lesser, rejected) role of researcher:
T6–N6–G: “I don’t think we ever think of ourselves as
being a researcher.”
Interviewer: “So – you always think of yourselves as
nurses?”
All: “Yes.”
T6–N1–G: “Nurses carrying out research, but not
researchers.”
Nurses had considerable influence in these RCTs over
which patients were informed about the RCT and how
it was presented to them. They strongly defended
their professional right to make decisions about these
things, but as they recounted decisions they had
made, they sometimes expressed strong personal
views about particular types of patients, the RCT
design, and its interventions. Most assumed they
could use their clinical judgment to decide who to
approach about the RCT and that they would be able
to do this, and recruit patients to the RCT, without
transmitting their views:
T2–N2: “[Patients] need to have great trust in their
[doctor], you know, that’s what I say to them. If you’re
happy with your [doctor], OK. If you’re not, it’s
probably not the trial for them to go into … I know I
must not have opinions on the studies and mustn’t
influence them but for their own peace of mind I think
they do need to have trust in their [doctor] just in case
they’re randomised to [intervention 1].”
T7–N3: “You can tell when you’re speaking to
patients, if they absolutely want the [organ] removed,
you’re not going to be able to sway them, and I don’t
think it would be ethical to try to be honest … I think
if it was me in the situation or my dad in the situation
I think I’d … rather [have intervention 1] … I keep
that inside my head … If someone asked me, what
would I do, if I can get out of answering the question, I
would, but I’d never lie to somebody.”
Some nurses were much more open with the inter-
viewer about how they could and did make decisions that
affected recruitment. In terms of their ability to decide
who would or would not be informed about the RCT, two
themes emerged.
Using discretion over whom to approach
Some nurses defended their right to use their discretion,
based on what they believed to be their clinical/caring or
advocacy role, and did so assertively. There may havebeen good clinical reasons for decisions, but in others, it
appeared to be their own discomfort with the process of
recruitment, or aspects of the RCT, and even prejudiced
views about particular groups or individuals:
T2–N3: “He was a very indecisive man generally, very
indecisive, and in the end he literally just couldn’t
make up his mind what he wanted to do … That’s a
nursing decision if you like. You get to know what
people are like and whether some – as I say like that
indecisive man, he wouldn’t have coped with [having
intervention 1]. You just know he wouldn’t because it’s
his nature.”
Interviewer: “Does that mean that you actually make
the final eligibility decision when you see the patient?
You might decide not to approach somebody, at that
point?”
T2–N3: “Yes I think that would be fair to say. Yes.”
T7–N3: “There was a patient who was young and he
was clinically eligible, and basically he wasn’t very
intelligent, and he would’ve been very easy to coerce to
get on the trial. He would’ve gone on it, but I didn’t
feel he was able to make a rational fully-informed
decision, so I made the decision that he wasn’t going
on the trial.”
T3–N2: “Sometimes you have to use your discretion
about who you approach and not. You can see that a
[potential participant] is there and she’s obviously very
stressed, she’s got a screaming child and you kind of think
‘I don’t think she’s going to take part in the study anyway
‘cause her stress levels are just too high.’ So you don’t.”
Apologising for ‘bothering’ potential participants and
avoiding recruitment
Some nurses found the decisions about who to approach
about the RCT so uncomfortable that they became very
hesitant. They became awkward and apologetic about
approaching potentially eligible patients, or found reasons
to avoid this discomfort:
T3–N1: “Recruiting [participants] to a study when
they’re ill, that’s the most difficult time to ask a
[participant] to take part in something. And that’s
quite difficult and at times I almost feel apologetic,
I think is the word, for approaching them … At the
beginning, there were times where I felt I don’t know
whether to approach them. I don’t know why, maybe
it’s stereotyping, maybe it’s the way they look, the way
they dress. I don’t know what else might be coming
in and affecting me but I’m thinking ‘I’m not sure
whether to approach them because I’m worried about
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difficult to approach families that you thought didn’t
speak English and that took quite a lot of courage on
my part because you’re in the middle of a health
centre, where everyone’s listening to you, and there’s
nothing worse than actually not being understood or
feeling that they’re not understanding you or that
you’re causing them concern as well so I found that
quite difficult … There was actually a [potential
participant] I didn’t approach last week in [location].
Her attitude at the desk was very aggressive … and I
thought I’m just not going there. No, so I didn’t.”
Nurses had considerable opportunities to inform patients
about ways to overcome organisational issues, but they
tended to just reinforce the difficulties, or transmit their
own views:
T2–N1: “I can’t imagine having been already told by
my doctor that this is what they are going to do for me
and then be told by somebody else that hang on a sec,
we are going to cancel all that and you could then
potentially have [another intervention] than had
already been scheduled. I mean I think that is a
massive stumbling block.”
T1–N1–G: “I haven’t recruited anyone to the trial. Of
the fifteen patients which have been registered, six of
them came to us from outside [city] … It wasn’t in my
conversation to ask these patients to be randomised
because they were coming for [intervention 1].”
T1-N2-G: “My patients are right smack bang in the
middle of a socially deprived area, very socially
deprived, not amazingly well educated – not to say
that everyone’s stupid because you get some who are
quite well educated – but the majority of them aren’t
and they’re just, so you know, they’ve just got these
preconceived ideas and they don’t want to think about
it. Cancer means they’re dead. That’s it … They don’t
want to go to [name of] hospital because they think
once they go … there, they’ll die because that’s where
you go to die. So you’re asking them to go there to have
[intervention 1], but they don’t want to go there
because that means they’re going to die.”
There were particular difficulties in T5 where the
nurses and researcher struggled to understand some of
the basic principles of the RCT design, and where they
also had strong personal treatment preferences:
T5–N3: “What is an RCT, sorry? … [Intervention 1] is
better and the reason why I believe that is that it
provides the extra support that the [patient] requires.”T5–N4–G: “A couple of our [patients] have gone along
and then they’ve got allocated to the control arm … I
know that it’s a randomised trial, I’ve done research
but from a clinician’s point of view – and this is what
we’ve always quite openly sort of communicated to the
[T5] project and this is why sometimes we have had
difficulties – because we’d like to sort of say ‘right okay
can we refer to the [intervention arm]?’”
T5–N1: “I feel a bit uncomfortable … The fact that I
want them to get the intervention group, I’m sure
that’s coming through. I was sure that I was sometimes
trying to downplay that but I’m sure that my voice
changes, there’s a lilt [laughs].”
Nurses identified recruitment barriers as being organ-
isational difficulties, the lack of patients fitting the RCT
eligibility criteria, and patients expressing strong treat-
ment preferences or rejecting randomisation. Analysis of
the interview data revealed, however, the nurses’ consid-
erable discomfort and difficulty in relation to their roles,
particularly in terms of which patients they approached
to discuss recruitment to the RCT, a lack of knowledge
for some about the RCT design, and their own views
about logistical issues, treatment preferences, and patient
characteristics. These views were expressed similarly by
those employed by the wider networks and in the specific
RCTs. It was also clear that many found their role as a
recruiter conflicted with their perception of their clinical,
caring, and advocacy responsibilities, leading to consider-
able discomfort and some clear instances of avoided
recruitment. As with the doctors, above, some of the
recruitment barriers could thus be seen to be originating
from, or being reinforced by, the nurses’ views. Their
unwillingness to approach individual or groups of patients
contributed to the lack of eligible participants. If patients
expressed a preference for treatment that accorded with
theirs or fitted their view of the logistical difficulties, it
was easy to allow them to have that treatment rather than
offer recruitment to the RCT.
Reconsidering barriers to recruitment: the need for
support and training for recruiters
The synthesis showed that the clear obstacles and hidden
challenges were found to some degree in all these RCTs.
In T6, with its dedicated research staff, a programme of
training and support was put in place for recruiters and
integrated into the recruitment activity [8]. A more
limited version of this intervention was included in the
other RCTs because of funding and time constraints, and
difficulties with engaging with the non-RCT funded
network nurses [13-15]. A number of key priorities for
training and support for recruiters emerged from the
synthesis, including:
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they understand and can communicate to patients
the key aspects of the RCT design, and can learn
how to gently elicit and explore patients’ perceptions
of intervention preferences and logistical challenges
rather than reflecting their own views.
 For doctors: support to ensure they are committed
to the RCT design and comfortable with the
eligibility criteria and all intervention options.
 For nurses: support in relation to perceived conflicts
in their roles; training to ensure they do not stray
from clear clinical reasons for not approaching
potential participants, and training to enable them
to be comfortable with approaching all eligible
patients.
The insights from the synthesis about the recruitment
process and the roles of recruiters, as well as these training
priorities, will be added to an updated version of the
recruitment intervention in due course.
Discussion
This study has provided a clear understanding of the
perspectives of clinical staff attempting to recruit patients
to pragmatic complex intervention RCTs. The findings
highlight the fragility of the process of recruitment,
and the overt/covert, witting/unwitting influences that
recruiters can have on the success or otherwise of recruit-
ment to RCTs. Recruiters readily identified organisational
difficulties, fewer than expected eligible patients and
strong treatment preferences expressed by patients as the
key barriers inhibiting recruitment, but were seemingly
unaware of their own influences on these obstacles. A key
finding from this research was how much discomfort and
emotion recruiters expressed about their research and
clinical roles while also indicating strong commitment to
the RCT and research in general. Doctors emphasised the
complementarity of their roles as scientists and clinicians,
but were uncomfortable about particular groups or indi-
vidual patients, clashes with their clinical judgments, and
their own preferences for particular interventions. Nurses
identified conflicts arising from their roles as caring
nurses, patient advocates, and (somewhat denigrated)
recruiters/researchers. They were uncomfortable and
defensive about the decisions they made about whom to
approach about the RCT, sometimes avoiding ‘bothering’
patients, making ostensibly ‘clinical’ decisions that strayed
into personal views, even prejudices, and tended to trans-
mit their own views about treatments and organisational
difficulties.
Recruitment was very difficult in these RCTs, as it is in
many. There were many examples in the interviews of how
recruiters privileged their clinical roles and judgments over
recruitment, leading to large numbers of patients who weretechnically eligible for the RCT but who were not informed
about it, and many others who were subtly (or not so
subtly) manoeuvred towards a particular intervention for
reasons that might have been clinically appropriate but
more often reflected the recruiters’ views. It seems
plausible that these findings would also be present in
other pragmatic RCTs. They are novel because they help
to explain why problems with recruitment can persist
even when CIs work hard to resolve organisational prob-
lems that appear to be the source of the difficulties [2-6].
Recruiters in these RCTs often expressed strong commit-
ment to the RCTs, but they found the issues raised by
actually recruiting individual patients so discomforting
that they found ways to avoid it, keeping their discomforts
away from colleagues or RCT leaders.
Patients’ treatment preferences were identified as a
major reason for poor recruitment in all these RCTs, as
they were in other studies [16,17]. The nuanced analysis
in this study suggested that some (perhaps many) of these
preferences might actually be contributed to by the
recruiters’ own views. A recent study of 93 consecutive
recruitment appointments in T6 showed that patients’
treatment preferences ranged on a continuum from a strong
desire to receive a treatment to a mild wish, based on a range
of detailed or sparse, accurate or inaccurate information,
gleaned from a variety of formal and informal sources
[18]. When nurse recruiters carefully elicited and ex-
plored these preferences and provided detailed informa-
tion about the RCT and its interventions, only a minority
of patients remained committed to their initial preference,
and the majority (75 % of those who had originally
expressed a preference) became open to other options and
80 % of these then consented to randomisation [18]. The
evidence from this synthesis was that recruiters often
expected patients to have preferences, and when they
heard preferences that seemed to make sense because they
accorded with their own views, it was easy to accept them
on face value, without further exploration. Some re-
cruiters justified this by stating that it would be coercive
to pursue things further; the balance between coercion
and accepting stated preferences without checking they
are based on accurate information would benefit from
further investigation.
Doctors’ accounts showed that they were particularly
uncomfortable with the formal RCT inclusion/exclusion
criteria, reflecting concerns about ‘equipoise’. The litera-
ture on equipoise in relation to RCTs has largely been
theoretical, focusing on its use as the ethical justification
for randomisation [19-21]. The concept has been
strongly criticised for its lack of relevance to contem-
porary healthcare [22,23], but there is remarkably
little empirical research investigating how doctors talk
about or operationalise equipoise during RCT recruitment
(see, for an exception, [24]). In this study, most of the
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their reliance on a sense of uncertainty as a community of
experts, but they often went on to indicate their lack of
uncertainty (certainty) in relation to specific patients or
subgroups of patients or particular interventions. As a
result, they made their own decisions about whether to
apply the criteria fully or not, but did not raise these issues
with the RCT CIs. This ‘variable enactment of the protocol’
was also found in another qualitative study of clinical
centres in a single RCT [25], and is probably widespread.
Nurses were particularly vexed by the conflicts they
perceived in their roles. This has been found in other
small-scale studies, particularly for nurses working on
the boundary between clinical work and research
[26-28], but the influence on recruitment has not been
shown previously. Most nurses, whether employed by
central networks or by specific RCTs, saw research roles
as of lower status and were clear that their clinical role
would always come first ‘at the expense of the research’.
Their discomfort was covertly expressed through their
concerns about ‘not bothering’ patients with information
about the RCT, or making ‘clinical’ judgments. For most,
the discomfort caused anxiety; for a small number this
anxiety became quite severe. Ultimately, however, their
views and actions meant that many patients were not
approached for recruitment, or were influenced in their
decisions about treatments outside the RCT. It will be
interesting to see if this changes with the introduction of
initiatives such as the UK’s ‘OK to ask’ campaign encour-
aging patients to request research participation [29].
These issues have relevance for the increasing number
of RCTs that are currently being launched. RCTs are
needed so that only the most effective and cost-effective
healthcare interventions are used, but they are extremely
expensive to undertake. Failure to complete recruitment
wastes considerable resources, and fears of recruitment
difficulties mean that some key healthcare questions are
avoided. These findings suggest that training and support
for recruiters based on integrated qualitative studies to
investigate the enacted recruitment process, might help
with completing recruitment (as it did in T6, and to some
degree in T3 and T5), or in clearly identifying the issues
that led to the closure of T1 and T7.
The findings are also important in the context of the
increasingly important contribution that nurses make to
RCT recruitment. Over the past decade, nurses have
become the main workforce in network organisations
such as the UK NCRN, which co-ordinates recruitment
for cancer RCTs, including T1, T2, and T7 [29]. Many
have taken on this role without much formal training –
often simple courses in ‘good clinical practice’, or occasion-
ally more advanced specialist courses [30]. As recruitment
to RCTs is increasingly placed in the hands of nurses, if the
views expressed here have currency elsewhere, thenconsiderable opportunities for RCT recruitment are not
being taken. Nurses had considerable power to decide
which patients would be given information about the RCT,
justified by being the patient’s advocate. Advocacy is a rela-
tively new addition to nursing, and while it is often
promoted as a moral imperative, it is fraught with
dilemmas [31,32]. It will be important for further research
to examine the role of advocacy and clinical decision-
making in nurse-led recruitment. It was remarkable how
little insight nurses seemed to have about the judgments
they were making, and how little evidence there was that
they had taken time to check the veracity of their opinions
with patients. Training and support in T6 enabled nurses
to achieve very high rates of recruitment and informed
consent [8]. There was evidence in this synthesis that the
nurses still continued to exhibit some concerns about their
roles, but they had access to support that mitigated their
anxiety. These nurses, and those in T3, were easiest to
train because they were employed by the RCTs and time
was dedicated to it by the CI; it was very difficult to meet
with groups of nurses who were employed by the national
networks such as the NIHR NCRN because they were
responsible for recruitment to many RCTs and their super-
visors were unwilling for them to devote time to particular
RCTs. The intensive training and support in T6 may not
always be possible, but this synthesis has emphasized the
need for standard and continuing training for all nurse
recruiters, to include aspects of RCTs, roles, and social
awareness, and not just good clinical practice. It has also
been suggested that standard and continuing education is
needed for physicians about how participation in RCTs
varies from standard clinical practice [33]. The evidence
from this synthesis suggests that all recruiters (physicians,
surgeons, nurses, and other professionals) would benefit
from training incorporating basic and advanced details of
the RCT design and how to present treatments and
randomisation fairly and clearly.
Strengths and limitations
This study is the first detailed and wide ranging exploration
of the perspective of recruiters involved in recruitment in
several (six) pragmatic RCTs underway with recruitment
difficulties. A strength of the study was in the use of
qualitative methods to understand the perspectives of
those actively engaged in recruitment, producing a
detailed and rich synthesis that allowed a nuanced
understanding of the processes underlying recruitment
in each RCT across a range of clinical interventions,
recruitment methods, and contexts (Table 1). Qualitative
research methods are particularly suitable for gaining an
understanding of complex issues and systems and the
perspectives of particular individuals and groups.
The study has a number of limitations. The RCTs were
included pragmatically because they included or added a
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ment, and so might be different from other RCTs. There
was diversity in the RCTs in terms of clinical contexts,
but four involved oncology and three surgery. There
were differences in the numbers and characteristics of
those who were interviewed in the RCTs and interviews
and group discussions were analysed pragmatically – a
function of the different management and recruitment
arrangements. It is likely that only those most willing to
speak about the RCT and recruitment issues agreed to
be interviewed, and so there could be different views
among other recruiters. The data were collected across
quite a long time period because of the reliance on the
funding of the qualitative studies. Accumulating evi-
dence of this sort across complex studies is difficult and
this is the largest synthesis to date. The consistency of
findings over time suggests that the insights are robust,
but it cannot be ruled out that other or more recent
RCTs recruit better (although recruitment problems
remain the key challenge to RCTs today). It is important
to acknowledge that the RCTs here were all having re-
cruitment difficulties. Others may have ‘quick fix’ issues
that simple interventions such as telephone reminders,
etc., may solve [2,6]. However, for RCTs where the topic
is controversial or the evidence is contested, or interven-
tions are very different (including ‘no’ or ‘control’ inter-
vention arms), it is likely that patients and clinicians will
have strong views or preferences, and it may be that the
findings have most relevance for these most ‘challenging’
RCTs.
Conclusions
This study suggests that there are tremendous opportun-
ities to increase levels of RCT recruitment if some of the
basic and discomforting issues that trouble recruiters can
be explored and training put in place to support them
when undertaking this fragile activity. The study has
provided the insight that, while trial recruitment (random-
isation) is a simple event, it occurs at the end of a long
chain of activities leading from the design of the RCT,
through the operationalization of the protocol in clinical
settings, to the presentation (or not) of the RCT to
patients who have been investigated for eligibility. Recruit-
ment difficulties are often seen to arise from organisa-
tional issues, patient shortages, and strong intervention
preferences, but, as this synthesis has shown, many of
these issues probably reflect underlying issues among
recruiters in terms of knowledge and views about evi-
dence, equipoise, RCT design, role conflicts, specialty
interests, and particular personal preferences. The synthe-
sis showed that clear obstacles and hidden challenges were
found to some degree in all these RCTs, but their relative
importance varied in each case, underlining the particular
value of the qualitative research in understanding specificcontexts, and also the need for targeted and specific
(as well as generic) training.
Recruitment is a difficult activity because it disrupts the
usual doctor- (or nurse-) patient relationship. Training
and support are required to ensure recruiters understand
the principles of RCTs and can explain the rationale for
the RCT to potential participants, have commitment to
the RCT, are confident in admitting uncertainty, are
willing to approach all eligible patients, can elicit patient
preferences and explore underlying reasons for them, and
provide accurate information. It may be that this is not an
activity that all doctors and nurses can or should under-
take, and those with very strong views about treatments
or stereotyped views should clearly not undertake recruit-
ment. Those leading RCTs with recruitment difficulties
will need to consider how the ‘clear obstacles’ and ‘hidden
challenges’ likely to be operating can be addressed. The
support and training needs for doctors and nurses are
different but individual practitioners will need to acknow-
ledge the anxiety and emotion they experience and accept
training and support if we are to create a more resilient
recruitment process that engages patients and recruiters
more effectively.
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